86 related items for PubMed ID: 8107307
1. Combined therapy in children and adolescents with IgA nephropathy.
Murakami K, Yoshioka K, Akano N, Takemura T, Okada M, Aya N, Hino S, Miyazato H, Yagi K, Maki S.
Nihon Jinzo Gakkai Shi; 1994 Jan; 36(1):38-43. PubMed ID: 8107307
[Abstract] [Full Text] [Related]
2. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
McIntyre CW, Fluck RJ, Lambie SH.
Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
[Abstract] [Full Text] [Related]
3. The effect of treatment with prednisolone or cyclophosphamide-warfarin-dipyridamole combination on the outcome of patients with membranous nephropathy.
Shearman JD, Yin ZG, Aarons I, Smith PS, Woodroffe AJ, Clarkson AR.
Clin Nephrol; 1988 Dec; 30(6):320-9. PubMed ID: 3243041
[Abstract] [Full Text] [Related]
4. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial.
Walker RG, Yu SH, Owen JE, Kincaid-Smith P.
Clin Nephrol; 1990 Sep; 34(3):103-7. PubMed ID: 2225560
[Abstract] [Full Text] [Related]
5. Early intensive therapy for clinical remission of active IgA nephropathy: a three-year follow-up study.
Hotta O, Taguma Y, Kurosawa K, Sudo K, Suzuki K, Horigome I.
Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):967-73. PubMed ID: 8255008
[Abstract] [Full Text] [Related]
6. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T, Honda K, Nitta K, Yumura W, Nihei H.
Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
[Abstract] [Full Text] [Related]
7. A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: preliminary trial.
Kanno Y, Witt M, Okada H, Nemoto H, Sugahara S, Nakamoto H, Suzuki H.
Clin Exp Nephrol; 2003 Mar; 7(1):48-51. PubMed ID: 14586743
[Abstract] [Full Text] [Related]
8. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.
Tsuruya K, Harada A, Hirakata H, Mitsuiki K, Johko T, Kondoh H, Takechi S, Fujishima M.
Clin Nephrol; 2000 Jan; 53(1):1-9. PubMed ID: 10661476
[Abstract] [Full Text] [Related]
9. Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial.
Yoshikawa N, Honda M, Iijima K, Awazu M, Hattori S, Nakanishi K, Ito H, Japanese Pediatric IgA Nephropathy Treatment Study Group.
Clin J Am Soc Nephrol; 2006 May; 1(3):511-7. PubMed ID: 17699253
[Abstract] [Full Text] [Related]
10. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
Uzu T, Harada T, Ko M, Yamato M, Takahara K, Yamauchi A.
Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
[Abstract] [Full Text] [Related]
11. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
[Abstract] [Full Text] [Related]
12. Treatment of vasculitic IgA nephropathy.
Harper L, Ferreira MA, Howie AJ, Savage CO, Richards NT, Michael J, Adu D.
J Nephrol; 2000 Dec; 13(5):360-6. PubMed ID: 11063140
[Abstract] [Full Text] [Related]
13. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
Trimarchi H, Muryan A, Young P, Forrester M, Iotti A, Pereyra H, Lombi F, Seminario O, Alonso M, Iotti R.
Medicina (B Aires); 2007 Dec; 67(5):445-50. PubMed ID: 18051227
[Abstract] [Full Text] [Related]
14. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis.
Woo KT, Edmondson RP, Yap HK, Wu AY, Chiang GS, Lee EJ, Pwee HS, Lim CH.
Clin Nephrol; 1987 Feb; 27(2):56-64. PubMed ID: 3549083
[Abstract] [Full Text] [Related]
15. Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.
Shima Y, Nakanishi K, Kaku Y, Ishikura K, Hataya H, Matsuyama T, Honda M, Sako M, Nozu K, Tanaka R, Iijima K, Yoshikawa N, Japanese Pediatric IgA Nephropathy Treatment Study Group.
Pediatr Nephrol; 2018 Nov; 33(11):2103-2112. PubMed ID: 29987456
[Abstract] [Full Text] [Related]
16. Can immunosuppressive drugs slow the progression of IgA nephropathy?
Goumenos D, Ahuja M, Shortland JR, Brown CB.
Nephrol Dial Transplant; 1995 Nov; 10(7):1173-81. PubMed ID: 7478120
[Abstract] [Full Text] [Related]
17. [A prospective controlled study of sairei-to in childhood IgA nephropathy with focal/minimal mesangial proliferation. Japanese Pediatric IgA Nephropathy Treatment Study Group].
Yoshikawa N, Ito H, Sakai T, Takekoshi Y, Honda M, Awazu M, Ito K, Iitaka K, Koitabashi Y, Yamaoka K, Nakagawa K, Nakamura H, Matsuyama S, Seino Y, Takeda N, Hattori S, Ninomiya M.
Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):503-6. PubMed ID: 9283216
[Abstract] [Full Text] [Related]
18. Efficacy of multidrug therapy combined with mizoribine in children with diffuse IgA nephropathy in comparison with multidrug therapy without mizoribine and with methylprednisolone pulse therapy.
Kawasaki Y, Hosoya M, Suzuki J, Onishi N, Takahashi A, Isome M, Nozawa R, Suzuki H.
Am J Nephrol; 2004 Jul; 24(6):576-81. PubMed ID: 15550753
[Abstract] [Full Text] [Related]
19. Long-term corticosteroid and dipyridamole treatment of membranoproliferative glomerulonephritis type I in children.
Takeda A, Niimura F, Matsutani H.
Nihon Jinzo Gakkai Shi; 1995 Jun; 37(6):330-5. PubMed ID: 7666598
[Abstract] [Full Text] [Related]
20. [Effect of plasma exchange therapy on IgA nephropathy in children--a retrospective study].
Tsunoda Y.
Nihon Jinzo Gakkai Shi; 1995 Apr; 37(4):238-46. PubMed ID: 7602811
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
